Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 6, 2025 • 8:31 PM ET

Date/Time Source News Release
03/27/2024 08:30 AM EDT ACCESSWIRE Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity
01/02/2024 08:30 AM EST ACCESSWIRE Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc.
11/16/2023 08:30 AM EST ACCESSWIRE Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion
11/15/2023 12:00 PM EST ACCESSWIRE Odyssey Health, Inc. to Provide Company Update and Webcast for Shareholders
10/18/2023 08:30 AM EDT ACCESSWIRE Odyssey Health, Inc. Provides Update on Asset Purchase Agreement with Oragenics, Inc.
10/05/2023 06:30 AM EDT Business Wire Oragenics to Acquire Odyssey Health's Neurological Drug Technology Pipeline Including Concussion Drug Candidate
10/04/2023 08:30 AM EDT ACCESSWIRE Odyssey Health Inc. Begins Trading on the OTCQB
08/23/2023 08:30 AM EDT ACCESSWIRE Odyssey Health, Inc. Presents Concussion Treatment Data at the Military Health System Research Symposium - MHSRS
06/08/2023 08:30 AM EDT ACCESSWIRE Odyssey Health, Inc. Presents Data at the Special Operations Medical Association - Scientific Assembly
03/30/2023 08:30 AM EDT TheNewsWire Odyssey Health, Inc. Preparing for a Phase II Pharmaceutical Concussion Treatment
Page

Additional News

As of June 6, 2025 • 8:31 PM ET

Date/Time Source News Release
11/16/2023 10:26 AM EST SeekingAlpha Odyssey selects Syneos Health to support its IND application for treatment of concussion
10/05/2023 06:51 AM EDT SeekingAlpha Oragenics to acquire certain assets of Odyssey Health
02/07/2023 08:30 AM EST News Direct Odyssey Health, Inc. Forms Community-Based Partnership with David R. Metcalf Foundation for Military Concussion Research
01/12/2023 09:44 AM EST SeekingAlpha Odyssey Health to develop intranasal nerve agent antidote
12/01/2022 09:00 AM EST InvestorBrandNetwork Odyssey Health, Inc. (ODYY) To Give Corporate Update at Scheduled Annual Meeting of Stockholders in January 2023
11/29/2022 10:30 AM EST InvestorBrandNetwork Odyssey Health, Inc. (ODYY) Development of Neuropharmaceuticals for TBIs and CNS Maladies, Portends Competitiveness in Area of Unmet Medical Needs
11/23/2022 09:00 AM EST InvestorBrandNetwork InvestorNewsBreaks - Odyssey Health Inc. (ODYY) Reports on Concussion Drug Progress, Provides Corporate Update
11/22/2022 12:00 PM EST InvestorBrandNetwork World Cup 2022 to Feature New Protocol to Respond to Suspected Concussions
11/21/2022 10:30 AM EST InvestorBrandNetwork Odyssey Health, Inc. (ODYY) Expands Executive Team of New Subsidiary in Strategic Move to Strengthen Marketing of Concussion, Neurological Therapies
11/17/2022 01:30 PM EST InvestorBrandNetwork Surgical Team in Spain Completes First-Ever Intestinal Transplant
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.